Justin Oldham

 Justin Oldham
Associate Professor of Internal Medicine
Medical School
University of Michigan
1150 W. Medical Center Drive MSRBIII
Ann Arbor, Michigan 48109
[email protected]
Available to mentor
Justin Oldham
Justin Oldham
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    I am a pulmonary fibrosis specialist and director of the UM ILD program. As a PhD Epidemiologist and translational physician scientist, I conduct research aimed at developing blood-based biomarkers to accurately predict pulmonary fibrosis progression and treatment response.

    Qualifications
    • Fellowship
      University of Chicago, Chicago, United States
      2011 - 2016
      Postdoctoral Fellowship
    • Residency
      University of California at Davis, USA
      2006 - 2009
      Residency
    • PhD, Medicine
      University of Michigan Medical School, Ann Arbor, United States
      2022 - 2025
    • M.S., Medicine
      University of Chicago, United States
      2014 - 2016
    • M.D., Medicine
      University of Colorado, United States
      2002 - 2006
    • B.A., History
      University of Colorado, United States
      1997 - 2002

    Center Memberships
    • Center Member
      AI and Digital Health Innovation

    Research Overview

    Pulmonary fibrosis, proteomics, biomarkers, Epidemiology

    Recent Publications

     See All Publications
    • Journal Article
      Decline in lung function increases the risk of death in patients with idiopathic pulmonary fibrosis: a plain language summary
      Oldham JM, Neely ML, Wojdyla DM, Antao VC, Todd JL. Future Rare Diseases, 2026 Mar 12; 6 (1): DOI:10.1080/23995270.2026.2635365
    • Presentation
      Predicting ILD Progression with Precision
      2026 Apr 13;
    • Journal Article
      Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis—Associated Pulmonary Hypertension
      Zhyvylo I, Sood N, Pugashetti JV, Linderholm AL, Hsu SW, Oldham J, Chen CH, Goncharova EA. Pulmonary Circulation, 2026 Sep 1; 16 (3): DOI:10.1002/pul2.70349
    • Journal Article
      Progressive pulmonary fibrosis: a state-of-the-art review.
      Cottin V, Brown K, Flaherty KR, Kolb M, Lynch DA, Oldham J, Valenzuela C, Wijsenbeek M, Wells AU. Eur Respir J, 2026 Jun 11; DOI:10.1183/13993003.01557-2025
      PMID: 42276742
    • Journal Article
      A75-25 Immunosuppression in Interstitial Lung Disease: A Multi-center Clone-censor-weighting Analysis
      Pugashetti JV, Jee AS, Yu A, Hammoud N, Chua FJ, Yazbeck L, Lee CT, Liu GY, Adams TN, Adegunsoye AO, Wolters PJ, Strek ME, Oldham J, Molyneaux PL, Newton C. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.168 DOI:10.1093/ajrccm/aamag286.168
    • Journal Article
      Genome-wide association study of Idiopathic Pulmonary Fibrosis susceptibility using clinically-curated European-ancestry datasets.
      Chin D, Hernandez-Beeftink T, Donoghue L, Guillen-Guio B, Leavy OC, Adegunsoye A, Booth HL, CleanUP-IPF Investigators of the Pulmonary Trials Cooperative , Fahy WA, Fingerlin TE, Gooptu B, Hall IP, Hart SP, Hill MR, Hirani N, Johnson SR, Kaminski N, Lorenzo-Salazar JM, Ma S-F, McAnulty RJ, McCarthy MI, Stockwell AD, Maher TM, Millar AB, Molyneaux PL, Molina-Molina M, Navaratnam V, Neighbors M, Oldham JM, Parfrey H, Saini G, Sayers I, Sheng XR, Stewart ID, Strek ME, Tobin MD, Whyte MKB, Zarcone MC, Zhang Y, Martinez F, Yaspan BL, Reynolds CJ, Schwartz DA, Flores C, Noth I, Jenkins RG, Allen RJ, Wain LV. Eur Respir J, 2026 May 21; DOI:10.1183/13993003.00506-2026
      PMID: 42167781
    • Journal Article
      A109-05 Association of Short-Term Changes in Epithelial Proteins With Respiratory Hospitalization Risk in Patients With Idiopathic Pulmonary Fibrosis: Data From the IPF-PRO Registry
      Todd JL, Page C, Neely ML, Wu P, Belperio JA, Maher TM, Oldham JM, Palmer SM, Patel DC, Hesslinger C, Schlange T, investigators OBOTI-PR. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2407 DOI:10.1093/ajrccm/aamag162.2407
    • Journal Article
      A15-05 Screening for Interstitial Lung Disease Using Quantitative CT Thresholds
      Wang JM, Pugashetti JV, Murray S, Mohan N, Kang E, Kazerooni E, Flaherty KR, Belloli E, Sheth JS, O’Dwyer DN, Han MK, Hatt CR, Oldham J. American Journal of Respiratory and Critical Care Medicine, 2026 May 20; 212 (Supplement_1): aamag162.2203 DOI:10.1093/ajrccm/aamag162.2203

    Featured News & Stories

         bright blue background with lungs
    Department News

    CME Event - Updates in the Diagnosis and Treatment of Interstitial Lung Disease

    Join University of Michigan experts on Tuesday, January 27, 2026 from 2-3 pm for a free virtual panel discussion on the current updates in the diagnosis and treatment of interstitial lung disease.